—

PACS Group, Inc.(PACS)— 同类公司组

数据截至2026-10-07 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

PACS Group, Inc.的Closelook综合评分为54/100,在同类公司组内排名第5位(共8家)——组内评分最高的是DexCom Inc(66/100)。

名称综合动量质量估值信号距52周高点
PACS PACS Group, Inc.54684156info12.7%
FMS Fresenius Medical Care Corporation50323784info22.1%
ENSG The Ensign Group Inc48343746warn22.3%
RHC.AU Ramsay Health Care Ltd45912453ok2.6%
DXCM DexCom Inc66838138bear9.9%
ONC BeiGene, Ltd.64816532ok5.5%
MEDP Medpace Holdings Inc63817530ok10.9%
PTGX Protagonist Therapeutics Inc60776212info12.4%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-07

Quick answers

PACS Group, Inc.在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Fresenius Medical Care Corporation (FMS)、The Ensign Group Inc (ENSG)、Ramsay Health Care Ltd (RHC.AU)、DexCom Inc (DXCM)、BeiGene, Ltd. (ONC)、Medpace Holdings Inc (MEDP)、Protagonist Therapeutics Inc (PTGX)。

PACS相对同类公司的评分如何?

PACS Group, Inc.的综合评分为54/100,组内排名第5位(共8家),截至2026-10-07;组内最高综合评分为DexCom Inc(66/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.